Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Neuroinflammation as a mediator of the exaggerated Piezo2 and Exercise Pressor Reflex in Peripheral Artery Disease

Award Number: F31HL175929
ORGANIZATION: NATIONAL HEART, LUNG, & BLOOD INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: FELLOWSHIP/SCHOLARSHIP/STUDENT LOANS
PERIOD OF PERFORMANCE START DATE: 03/05/2025
PERIOD OF PERFORMANCE END DATE: 03/04/2030

Group Awards By:

View Award Description

Neuroinflammation as a mediator of the exaggerated Piezo2 and Exercise Pressor Reflex in Peripheral Artery Disease - Project Summary Peripheral artery disease (PAD) results in the progressive reduction of blood flow to peripheral body parts including the lower limbs. The resulting ischemic muscle triggers an increased arterial pressure during lower limb movements that is due to an exaggerated exercise pressor reflex (EPR). The EPR is a neural feedback mechanism that leads to a physiological increase in blood pressure upon muscle contraction. When the EPR is exaggerated in PAD, such that even low levels of muscle contraction (e.g., elicited by walking) cause abnormally high blood pressure responses. This significantly contributes to the high risk of cardiovascular morbidity and mortality in patients with PAD. Therefore, exercise, which has been shown to be beneficial for improving muscle function and repair in patients with PAD cannot be safely prescribed to the patients. This emphasizes the need for therapies that can normalize the EPR. The mechanically sensitive arm of the EPR mediates its exaggeration in PAD, as has been shown by rodent femoral artery ligation (FAL), a well-established model of PAD. FAL chronically sensitizes the mechanically sensitive receptors e.g., Piezo2, but the mechanism is unknown. Preliminary studies from our lab show that Piezo2, in part, mediates the exaggerated EPR. The ischemic muscles of patients and rodent models with PAD exhibit increased expression of pro-inflammatory genes and immune cell infiltration. The effect that the resulting inflammatory cytokines from the ischemic muscle has on the muscle mechanosensitive afferent neurons and their resident ion channels is unknown. Previous findings have reported a signal transduction pathway that begins with an inflammatory mediator and culminates in the heightened activity of a mechanosensitive channel in somatosensory neurons. Therefore, the hypothesis of this proposal is that the pro-inflammatory signals from the ischemic muscle increase the expression and activity of Piezo2 channels in mechanosensitive afferent neurons. To test this hypothesis, the proposed aims (Aim 1) will determine the effect of proinflammatory mediators on the activity and expression of Piezo2 channel and other mechanosensitive channels in mouse dorsal root ganglia (DRG) sensory neurons and hiPSC-derived sensory neurons (hiPSC-SN). The effects of proinflammatory mediators in the absence of ischemia on Piezo2 and other mechanosensitive channels’ expression and activity will also be investigated in vivo. To establish a definitive cause-and-effect relationship between muscle inflammation and Piezo2 sensitization, the proposed experiments involve macrophage depletion under ischemic conditions. The effects of this depletion on the activity and expression of Piezo2 and other mechanosensitive channels in the DRG will be investigated. The resulting findings will offer insights into the interplay between neural and immune responses in PAD, potentially leading to novel therapeutic strategies to better managing the cardiovascular risks associated with PAD, especially during exercise. Beyond the immediate aims, these findings could inform research into other cardiovascular diseases where ischemia and inflammation play critical roles.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $35,637 )
2026	2026	REGENTS OF THE UNIVERSITY OF MINNESOTA	2221 UNIVERSITY AVE SE STE 100	MINNEAPOLIS	MN	55414	HENNEPIN	USA	Cardiovascular Diseases Research	000	2	3/6/2026	NON-COMPETING CONTINUATION	$35,637
														Subtotal = $35,637

Issue Date FY: 2025 ( Subtotal = $0 )
2025	2024	REGENTS OF THE UNIVERSITY OF MINNESOTA	200 OAK ST SE	MINNEAPOLIS	MN	55455	HENNEPIN	USA	Cardiovascular Diseases Research	000	1	3/20/2025	NEW	$0
														Subtotal = $0

Issue Date FY: 2024 ( Subtotal = $40,431 )
2024	2024	REGENTS OF THE UNIVERSITY OF MINNESOTA	200 OAK ST SE	MINNEAPOLIS	MN	55455	HENNEPIN	USA	Cardiovascular Diseases Research	000	1	9/5/2024	NEW	$40,431
														Subtotal = $40,431

Grand Total All Awards = $76,068

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Neuroinflammation as a mediator of the exaggerated Piezo2 and Exercise Pressor Reflex in Peripheral Artery Disease

Award Number: F31HL175929

ORGANIZATION: NATIONAL HEART, LUNG, & BLOOD INSTITUTE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: FELLOWSHIP/SCHOLARSHIP/STUDENT LOANS

PERIOD OF PERFORMANCE START DATE: 03/05/2025

PERIOD OF PERFORMANCE END DATE: 03/04/2030

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer